P01.041 Secondary prophylaxis with romiplostim for temozolomide-induced thrombocytopenia in newly diagnosed glioblastoma

MLA

O Chinot, et al. P01.041 Secondary Prophylaxis with Romiplostim for Temozolomide-Induced Thrombocytopenia in Newly Diagnosed Glioblastoma. Sept. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....614168372b6851af9ddd399bbe7c025f&authtype=sso&custid=ns315887.

APA

O Chinot, E. Le Rhun, Michael Weller, Stéphanie Cartalat-Carel, François Dubois, A Di Stefano, Nicolas Reyns, Caroline Houillier, & Patrick Devos. (2018). P01.041 Secondary prophylaxis with romiplostim for temozolomide-induced thrombocytopenia in newly diagnosed glioblastoma.

Chicago

O Chinot, E. Le Rhun, Michael Weller, Stéphanie Cartalat-Carel, François Dubois, A Di Stefano, Nicolas Reyns, Caroline Houillier, and Patrick Devos. 2018. “P01.041 Secondary Prophylaxis with Romiplostim for Temozolomide-Induced Thrombocytopenia in Newly Diagnosed Glioblastoma,” September. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....614168372b6851af9ddd399bbe7c025f&authtype=sso&custid=ns315887.